NCT05033301 Evaluating the Effectiveness of the Nurse Ned Clinic
| NCT ID | NCT05033301 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Health Network, Toronto |
| Condition | Prostate Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2021-11-15 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2021-11-15 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this non-randomized control trial is to evaluate the effectiveness of a virtual nurse-led survivorship clinic for prostate cancer (PCa) survivors. Through this trial, investigators will compare pre-determined survivorship outcomes of men receiving care via traditional specialist-led PCa virtual care model (Specialist Ned) to those receiving care via the newly-proposed nurse-led PCa virtual care model (Nurse Ned). In total, it is anticipated that a maximum of 600 men (300 in control arm; 300 in intervention arm) across five clinical sites (3 in Ontario; 1 in Alberta; and 1 in Nova Scotia) will be enrolled into this trial and will be followed for 12 months.
Eligibility Criteria
Inclusion Criteria: 1. 18 years of age or older 2. Completed curative-intent treatment 3. Receiving PCa survivorship care at University Health Network (UHN), Trillium Health Partners (THP), Niagara Health System (NHS), Prostate Cancer Centre - Calgary (PCCC), or Queen Elizabeth II Health Sciences Centre (QEII HSC)-affiliated hospital 4. Low risk of recurrence as determined by their treatment specialist 5. Adequate English ability (or a caregiver willing to provide translation) to complete study activities as determined by research assistant 6. Have an email address (or be able to use the email address of a caregiver) Exclusion Criteria: Patients with metastatic PCa are not eligible to participate in this research.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05033301 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05033301 currently recruiting?
Yes, NCT05033301 is actively recruiting participants. Contact the research team at denise.ng@uhn.ca for enrollment information.
Where is the NCT05033301 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT05033301 clinical trial?
NCT05033301 is sponsored by University Health Network, Toronto. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.